Posts

Oura and UC San Diego Health launch smart-ring study of obesity treatment outcomes

on
Oura and UC San Diego Health have launched SMART-BMI, a multi-year clinical study examining whether continuous Oura Ring data can help explain outcomes for people receiving GLP-1 medications or bariatric surgery. The ring will track signals such as sleep, heart rate and physical activity between clinic visits. Researchers will compare these patterns with outcomes including weight loss, HbA1c (average blood sugar), blood pressure, cholesterol, quality of life and—among GLP-1 users—whether patients remain on treatment. Reports say the study plans to enroll about 260 participants and includes a phase testing whether making ring data available to care teams can improve outcomes. The study is registered as NCT07736729. The trial is intended to investigate whether wearable data is useful in obesity care; it has not yet produced results. Oura says the ring is not a medical device. Sources: Oura expands clinical research with obesity treatment study ŌURA and UC San Diego Health Lau...

HHS eases enforcement for six unapproved wellness peptides

on

Merck plans another investment-heavy year in 2027

on

Bristol Myers beats Q3 revenue estimates, but Cobenfy sales disappoint

on

LENZ cuts workforce as it shifts toward consumer marketing

on

Anthropic pushes further into biotech with one-person startup acquisition

on

Lilly raises revenue outlook again as Mounjaro and Zepbound demand drives a strong quarter

on

Cash-pay is becoming a key growth channel for Lilly’s weight-loss drugs

on

Flood damage at Pfizer–Zydus India plant may prolong cancer drug shortages

on

Enveda and Anthropic use Claude to speed drug-development paperwork

on

Survey finds rising optimism that AI will speed drug discovery

on

Astellas takes option on Audax’s preclinical IL-12 cancer drug

on

Lilly says retatrutide beat Ozempic on blood sugar and weight loss

on